Patient-Controlled Transcutaneous Acupoint Electrical Stimulation to Improve Quality of Life in Patients With Cancer Pain
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Cancer Pain
- Sponsor
- Yi Liang
- Enrollment
- 94
- Primary Endpoint
- Trial feasibility
- Status
- Not yet recruiting
- Last Updated
- last year
Overview
Brief Summary
The conduct of a pilot trial is of great significance as a means of assessing the feasibility and harmonization of the research and is a very necessary precursor to the better conduct of formal trials. The primary aim of this pilot study is to assess the feasibility of a PC-TEAS in improving the quality of life of cancer patients with pain, with the aspiration of providing process evidence base and an assessment of the intervention for conducting a formal trial. the secondary outcome is to assess the clinical efficacy of the PC-TEAS.
Investigators
Yi Liang
Principal Investigator
The Third Affiliated hospital of Zhejiang Chinese Medical University
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Trial feasibility
Time Frame: week 4
The feasibility of the proposed approach will be evaluated by the number who agreed to participate in the trial.
Secondary Outcomes
- the changes of EORTC QLQ-C30 score from baseline(week 4, week 8, week 12)
- the changes in BPI score of mean pain, severe Pain, least pain and current pain from baesline(week 4, week 8, week 12)
- the amounts of analgesics used(week 4, week 8, week 12)
- Index of spontaneous bowel movements(week 4, week 8, week 12)
- The changes in mood scale scores of Hamilton Rating Scale for Depression (HAM-D)(week 4, week 8, week 12)
- The changes in mood scale scores of Hamilton Rating Scale for Hamilton Rating Scale for Anxiety (HAM-A)(week 4, week 8, week 12)